PAR-1: A Potential Drug Target for Pancreatic Cancer (G145624)
PAR-1: A Potential Drug Target for Pancreatic Cancer
PAR-1 (Pancreatic cancer associated with the Ku70 gene) is a protein that is expressed in pancreatic cancer cells. It is a known gene that has been associated with the development of pancreatic cancer. PPAR-1 has also been identified as a potential drug target in the treatment of pancreatic cancer.
PAR-1 is a transducing RNA (RNA-mediated transport) gene, which plays an important role in tumorigenesis. It is expressed in a variety of cancers, including pancreatic, lung, breast, and ovarian cancers. In pancreatic cancer, the expression level of PAR-1 is high, and its expression level is closely related to the severity and prognosis of the disease.
The protein encoded by the PAR-1 gene is a transducing RNA that transports materials within cells. In cancer cells, the PAR-1 protein is often expressed at high levels, making it a potential drug target.
Scientists have discovered that the PAR-1 protein has great potential in treating pancreatic cancer. For example, PAR-1 inhibitors have been shown to inhibit the growth and spread of pancreatic cancer cells. In addition, PAR-1 inhibitors can also inhibit the angiogenesis of tumor cells, thus providing a new approach for the treatment of pancreatic cancer.
In addition, the PAR-1 gene is also considered an important biomarker for the diagnosis and prognosis of pancreatic cancer. Since the expression level of PAR-1 protein is high in pancreatic cancer, the severity and prognosis of pancreatic cancer can be assessed by detecting the level of PAR-1 protein.
Overall, the PAR-1 protein is a potential drug target for the treatment of pancreatic cancer. Future research will continue to further investigate the role of PAR-1 protein in the treatment of pancreatic cancer and provide new guidance for clinical practice.
Protein Name: Prader Willi/Angelman Region RNA 1
More Common Targets
PWAR4 | PWAR5 | PWAR6 | PWARSN | PWP1 | PWP2 | PWRN1 | PWRN2 | PWRN3 | PWWP2A | PWWP2B | PWWP3A | PWWP3B | PXDC1 | PXDN | PXDNL | PXK | PXMP2 | PXMP4 | PXN | PXN-AS1 | PXT1 | PXYLP1 | PYCARD | PYCR1 | PYCR2 | PYCR3 | PYDC1 | PYDC2 | PYDC2-AS1 | PYGB | PYGL | PYGM | PYGO1 | PYGO2 | PYHIN1 | PYM1 | PYROXD1 | PYROXD2 | Pyruvate Dehydrogenase Complex | Pyruvate dehydrogenase kinase | Pyruvate Kinase | PYY | PYY2 | PZP | QARS1 | QDPR | QKI | QPCT | QPCTL | QPRT | QRFP | QRFPR | QRICH1 | QRICH2 | QRSL1 | QSER1 | QSOX1 | QSOX2 | QTRT1 | QTRT2 | Queuine tRNA-ribosyltransferase | R-Spondin | R3HCC1 | R3HCC1L | R3HDM1 | R3HDM2 | R3HDM4 | R3HDML | R3HDML-AS1 | RAB GTPase | RAB10 | RAB11A | RAB11AP2 | RAB11B | RAB11B-AS1 | RAB11FIP1 | RAB11FIP2 | RAB11FIP3 | RAB11FIP4 | RAB11FIP5 | RAB12 | RAB13 | RAB14 | RAB15 | RAB17 | RAB18 | RAB19 | RAB1A | RAB1B | RAB20 | RAB21 | RAB22A | RAB23 | RAB24 | RAB25 | RAB26 | RAB27A | RAB27B | RAB28